REPORT ID 6564

EMEA (Europe, Middle East and Africa) Pharmaceutical Grade Marijuana Market Report 2017

Publish Date
26-Dec-17
Pages
109
Format
Electronic (PDF)

In this report, the EMEA Pharmaceutical Grade Marijuana market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Pharmaceutical Grade Marijuana for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Pharmaceutical Grade Marijuana market competition by top manufacturers/players, with Pharmaceutical Grade Marijuana sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Merck
    Pharmos
    GW Pharmaceuticals
    Valeant Pharmaceuticals International
    Unimed Pharmaceuticals
    Solvay Pharmaceuticals
    Sanofi-Aventis
    Medical Marijuana Inc
    Teva Pharmaceutical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Sativex
    Cesamet
    Marinol
    Dexanabinol
    Cannabinor
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Research & Academic Laboratories
    Pharmaceutical & Biotechnology Companies
    Hospitals

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Pharmaceutical Grade Marijuana Market Report 2017
1 Pharmaceutical Grade Marijuana Overview
    1.1 Product Overview and Scope of Pharmaceutical Grade Marijuana
    1.2 Classification of Pharmaceutical Grade Marijuana
        1.2.1 EMEA Pharmaceutical Grade Marijuana Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Pharmaceutical Grade Marijuana Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Sativex
        1.2.4 Cesamet
        1.2.5 Marinol
        1.2.6 Dexanabinol
        1.2.7 Cannabinor
        1.2.8 Others
    1.3 EMEA Pharmaceutical Grade Marijuana Market by Application/End Users
        1.3.1 EMEA Pharmaceutical Grade Marijuana Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Research & Academic Laboratories
        1.3.3 Pharmaceutical & Biotechnology Companies
        1.3.4 Hospitals
    1.4 EMEA Pharmaceutical Grade Marijuana Market by Region
        1.4.1 EMEA Pharmaceutical Grade Marijuana Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Pharmaceutical Grade Marijuana (2012-2022)
        1.5.1 EMEA Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Pharmaceutical Grade Marijuana Revenue and Growth Rate (2012-2022)

2 EMEA Pharmaceutical Grade Marijuana Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Pharmaceutical Grade Marijuana Market Competition by Players/Manufacturers
        2.1.1 EMEA Pharmaceutical Grade Marijuana Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Pharmaceutical Grade Marijuana Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Pharmaceutical Grade Marijuana Sale Price by Players (2012-2017)
    2.2 EMEA Pharmaceutical Grade Marijuana (Volume and Value) by Type/Product Category
        2.2.1 EMEA Pharmaceutical Grade Marijuana Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Pharmaceutical Grade Marijuana Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Pharmaceutical Grade Marijuana Sale Price by Type (2012-2017)
    2.3 EMEA Pharmaceutical Grade Marijuana (Volume) by Application
    2.4 EMEA Pharmaceutical Grade Marijuana (Volume and Value) by Region
        2.4.1 EMEA Pharmaceutical Grade Marijuana Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Pharmaceutical Grade Marijuana Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Pharmaceutical Grade Marijuana Sales Price by Region (2012-2017)

3 Europe Pharmaceutical Grade Marijuana (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Pharmaceutical Grade Marijuana Sales and Value (2012-2017)
        3.1.1 Europe Pharmaceutical Grade Marijuana Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Pharmaceutical Grade Marijuana Revenue and Growth Rate (2012-2017)
    3.2 Europe Pharmaceutical Grade Marijuana Sales and Market Share by Type
    3.3 Europe Pharmaceutical Grade Marijuana Sales and Market Share by Application
    3.4 Europe Pharmaceutical Grade Marijuana Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Pharmaceutical Grade Marijuana Sales Volume by Countries (2012-2017)
        3.4.2 Europe Pharmaceutical Grade Marijuana Revenue by Countries (2012-2017)
        3.4.3 Germany Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2017)
        3.4.4 France Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2017)
        3.4.5 UK Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2017)
        3.4.6 Russia Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2017)
        3.4.7 Italy Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2017)

4 Middle East Pharmaceutical Grade Marijuana (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Pharmaceutical Grade Marijuana Sales and Value (2012-2017)
        4.1.1 Middle East Pharmaceutical Grade Marijuana Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Pharmaceutical Grade Marijuana Revenue and Growth Rate (2012-2017)
    4.2 Middle East Pharmaceutical Grade Marijuana Sales and Market Share by Type
    4.3 Middle East Pharmaceutical Grade Marijuana Sales and Market Share by Application
    4.4 Middle East Pharmaceutical Grade Marijuana Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Pharmaceutical Grade Marijuana Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Pharmaceutical Grade Marijuana Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2017)
        4.4.4 Israel Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2017)
        4.4.5 UAE Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2017)
        4.4.6 Iran Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2017)

5 Africa Pharmaceutical Grade Marijuana (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Pharmaceutical Grade Marijuana Sales and Value (2012-2017)
        5.1.1 Africa Pharmaceutical Grade Marijuana Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Pharmaceutical Grade Marijuana Revenue and Growth Rate (2012-2017)
    5.2 Africa Pharmaceutical Grade Marijuana Sales and Market Share by Type
    5.3 Africa Pharmaceutical Grade Marijuana Sales and Market Share by Application
    5.4 Africa Pharmaceutical Grade Marijuana Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Pharmaceutical Grade Marijuana Sales Volume by Countries (2012-2017)
        5.4.2 Africa Pharmaceutical Grade Marijuana Revenue by Countries (2012-2017)
        5.4.3 South Africa Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Pharmaceutical Grade Marijuana Sales and Growth Rate (2012-2017)

6 EMEA Pharmaceutical Grade Marijuana Manufacturers/Players Profiles and Sales Data
    6.1 Merck
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Pharmaceutical Grade Marijuana Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Merck Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Pharmos
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Pharmaceutical Grade Marijuana Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Pharmos Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GW Pharmaceuticals
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Pharmaceutical Grade Marijuana Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GW Pharmaceuticals Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Valeant Pharmaceuticals International
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Pharmaceutical Grade Marijuana Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Valeant Pharmaceuticals International Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Unimed Pharmaceuticals
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Pharmaceutical Grade Marijuana Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Unimed Pharmaceuticals Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Solvay Pharmaceuticals
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Pharmaceutical Grade Marijuana Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Solvay Pharmaceuticals Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Sanofi-Aventis
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Pharmaceutical Grade Marijuana Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Sanofi-Aventis Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Medical Marijuana Inc
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Pharmaceutical Grade Marijuana Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Medical Marijuana Inc Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Teva Pharmaceutical
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Pharmaceutical Grade Marijuana Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Teva Pharmaceutical Pharmaceutical Grade Marijuana Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Pharmaceutical Grade Marijuana Manufacturing Cost Analysis
    7.1 Pharmaceutical Grade Marijuana Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Pharmaceutical Grade Marijuana

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Pharmaceutical Grade Marijuana Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Pharmaceutical Grade Marijuana Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Pharmaceutical Grade Marijuana Market Forecast (2017-2022)
    11.1 EMEA Pharmaceutical Grade Marijuana Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Pharmaceutical Grade Marijuana Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Pharmaceutical Grade Marijuana Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Pharmaceutical Grade Marijuana Price and Trend Forecast (2017-2022)
    11.2 EMEA Pharmaceutical Grade Marijuana Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Pharmaceutical Grade Marijuana Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Pharmaceutical Grade Marijuana Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Pharmaceutical Grade Marijuana Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Pharmaceutical Grade Marijuana Sales Forecast by Type (2017-2022)
    11.7 EMEA Pharmaceutical Grade Marijuana Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer